2024 Archives - Page 2 of 10 - Institut Pasteur

Development of a pathogenicity score based on machine learning for the prioritisation of genomic variants in the context of medical genomics

Development of a pathogenicity score based on machine learning for the prioritisation of genomic variants in the context of medical genomics

by Sabrina | Oct 29, 2024 | 2024, Thesis

A machine-learning-based classification of small cell lung cancer subtypes: implications for prognosis and therapy selection

A machine-learning-based classification of small cell lung cancer subtypes: implications for prognosis and therapy selection

by Sabrina | Oct 27, 2024 | 2024, Thesis

Sequencing and analysis of circulating RNAs by REJOIN-seq and small RNA-seq in liquid biopsies

Sequencing and analysis of circulating RNAs by REJOIN-seq and small RNA-seq in liquid biopsies

by Sabrina | Oct 25, 2024 | 2024, Thesis

Role of signal regulatory protein alpha (SIRPA) in the antiviral response

Role of signal regulatory protein alpha (SIRPA) in the antiviral response

by Sabrina | Oct 25, 2024 | 2024, Thesis

Sequencing and analysis of circulating RNAs by REJOIN-seq and small RNA-seq in liquid biopsies

Profiles of circulating non-coding small RNAs in women with Systemic Lupus Erythematosus

by Sabrina | Oct 10, 2024 | 2024, Thesis

Evaluation of the antiviral and immunomodulatory properties of synthetic peptides derived from signal-regulatory protein alpha (SIRPA) protein

Evaluation of the antiviral and immunomodulatory properties of synthetic peptides derived from signal-regulatory protein alpha (SIRPA) protein

by Sabrina | Sep 22, 2024 | 2024, Thesis

« Older Entries

Next Entries »

Vortex Profit Max

Visita High Sierra Corp Uruguay para análisis y reseñas de suplementos de salud. Para detalles sobre Elastica Crema, accede directamente aquí: Elastica Crema en Uruguay.